Stevanato Group Announces Public Offering of Ordinary Shares
PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment,…
Pharmaceuticals, Biotechnology and Life Sciences
PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment,…
Recognized for Emissions Reductions Through its Supply Chain CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug…
Asserts CSG has acted in bad faith, ignoring obligations as strategic partner for Spotfire® software WALTHAM, Mass.–(BUSINESS WIRE)–Today, Revvity, Inc.…
Abecma demonstrated superiority over standard regimens in the Phase 3 KarMMa-3 trial, with a 51% reduction in risk of disease…
Conference call to be on Wednesday, April 3, 2024, at 5 p.m. EDT LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP)…
Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today EMERYVILLE, Calif.–(BUSINESS WIRE)–OmniAb, Inc. (NASDAQ: OABI) today reported financial…
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for…
Site to supply products to customers for development and production of biologics New Bioprocessing Production Center in Daejeon strengthens company’s…
– Interim Data: Study Achieves Primary End Point Demonstrating Clinical and Statistically Significant Reductions Compared to Placebo in Agitation Associated…
Development of next-generation sequencing companion diagnostics (CDx) Goal is to help increase patient access to Bayer’s precision cancer therapies by…